|
risk free rate
|
|
8
|
1012
|
May 12, 2015
|
|
H model to value stock
|
|
1
|
1070
|
May 7, 2015
|
|
EVA & NOPAT
|
|
3
|
877
|
May 6, 2015
|
|
Reading 39 : Equity Risk Premium in integrated markets (International CAPM)
|
|
1
|
895
|
May 6, 2015
|
|
Control perspective in valuation
|
|
3
|
3614
|
May 6, 2015
|
|
Ibbotson-Chen ERP: What the he** is this?
|
|
1
|
870
|
May 3, 2015
|
|
Schweser Exam 1 AM - #19
|
|
0
|
849
|
May 2, 2015
|
|
CFO - under IFRS and US GAAP
|
|
2
|
1117
|
April 30, 2015
|
|
The Fama–French Model
|
|
1
|
886
|
April 30, 2015
|
|
FCFE and FCFF - effects of financial leverage
|
|
2
|
1151
|
April 29, 2015
|
|
Valuing high growth, private companies
|
|
0
|
906
|
April 28, 2015
|
|
Fama-French Model / Baseline sensitivities for Beta
|
|
3
|
1029
|
April 28, 2015
|
|
Residual Income valuation
|
|
1
|
903
|
April 24, 2015
|
|
Residual Income valuation
|
|
1
|
926
|
April 23, 2015
|
|
justified P/BV formula
|
|
3
|
1030
|
April 22, 2015
|
|
FCFF-Change in WC
|
|
2
|
921
|
April 20, 2015
|
|
Enterprise Value
|
|
2
|
885
|
April 19, 2015
|
|
Justified Price Mutiples
|
|
3
|
971
|
April 19, 2015
|
|
Reading 36: Residual Income, CFAI Practice Problem 5 - why NOPAT/Assets vs WACC?
|
|
0
|
924
|
April 18, 2015
|
|
premium over book value/ RI model
|
|
2
|
1168
|
April 15, 2015
|
|
playing with GGM
|
|
7
|
1108
|
April 15, 2015
|
|
Different PVGO formulas in Curriculum 2014 and Schweser 2013
|
|
16
|
1143
|
April 12, 2015
|
|
DDM 2nd Stage: Finding r
|
|
4
|
966
|
April 12, 2015
|
|
FCFE
|
|
3
|
906
|
April 5, 2015
|
|
EBIT and Operating Profit
|
|
1
|
1055
|
April 4, 2015
|
|
Fixed Capital Investments - FCInv
|
|
2
|
1320
|
April 4, 2015
|
|
Non-Cash Charge Terminology
|
|
1
|
906
|
March 28, 2015
|
|
Reading 33 Example 6 on page 239-241 - Gordon Growth vs Bond Yield Plus Risk Premium
|
|
5
|
867
|
March 23, 2015
|
|
Asset value
|
|
4
|
914
|
March 20, 2015
|
|
Interest rate tax shield when using EBIT/EBITDA for FCFF
|
|
3
|
1760
|
March 19, 2015
|